ArticleVaccines2022

Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms.

Reka Varnai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.